glp-1 drugs and parkinson's disease Are we measuring the wrong primary outcome for for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep Ozempic and other GLP-1 drugs

Additionally, GO has shown promise as a bioimaging tool for tumor cells

In patients who have both CD and HT, gluten withdrawal may also improve the inflammatory context in which thyroid autoimmunity operates

since HbA1c levels represent blood glucose levels in the last 23 months, probably 12 weeks of intervention cannot have a significant effect on HbA1c levels in subjects with a long history of diabetes

1 2 Kanzok SM, Fechner A, Bauer H, Ulschmid JK, Mller HM, Botella-Munoz J, Schneuwly S, Schirmer R, Becker K (2001)

The combined effect across both blends centers on four processes: angiogenesis, cellular migration, collagen synthesis, and, in the case of KLOW, NF-kB pathway inhibition